Sirona Biochem (STU:ZSB) FCF Margin % : -37,100.00% (As of Jan. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Sirona Biochem FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Sirona Biochem's Free Cash Flow for the three months ended in Jan. 2024 was €-0.37 Mil. Sirona Biochem's Revenue for the three months ended in Jan. 2024 was €0.00 Mil. Therefore, Sirona Biochem's FCF Margin % for the quarter that ended in Jan. 2024 was -37,100.00%.

As of today, Sirona Biochem's current FCF Yield % is -12.57%.

The historical rank and industry rank for Sirona Biochem's FCF Margin % or its related term are showing as below:

STU:ZSB' s FCF Margin % Range Over the Past 10 Years
Min: -53500 Med: -1522 Max: -46.36
Current: -5684

During the past 13 years, the highest FCF Margin % of Sirona Biochem was -46.36%. The lowest was -53500.00%. And the median was -1522.00%.

STU:ZSB's FCF Margin % is ranked worse than
88.78% of 1034 companies
in the Biotechnology industry
Industry Median: -148.935 vs STU:ZSB: -5684.00

Sirona Biochem FCF Margin % Historical Data

The historical data trend for Sirona Biochem's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sirona Biochem FCF Margin % Chart

Sirona Biochem Annual Data

Trend

Oct14

Oct15

Oct16

Oct17

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

FCF Margin %

Get a 7-Day Free Trial

-2,622.58

-2,041.18

-804.30

-324.30

-5,058.33

Sirona Biochem Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
FCF Margin %	Get a 7-Day Free Trial															-	-1,253.66	-7,380.00	759.09	-37,100.00

Competitive Comparison of Sirona Biochem's FCF Margin %

For the Biotechnology subindustry, Sirona Biochem's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sirona Biochem's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sirona Biochem's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Sirona Biochem's FCF Margin % falls into.

Sirona Biochem FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Sirona Biochem's FCF Margin for the fiscal year that ended in Oct. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Oct. 2023 )	/	Revenue (A: Oct. 2023 )
	=	-1.214	/	0.024
	=	-5,058.33 %

Sirona Biochem's FCF Margin for the quarter that ended in Jan. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Jan. 2024 )	/	Revenue (Q: Jan. 2024 )
	=	-0.371	/	0.001
	=	-37,100.00 %

Sirona Biochem FCF Margin % Related Terms

Thank you for viewing the detailed overview of Sirona Biochem's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Sirona Biochem (STU:ZSB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sirona Biochem Corp (STU:ZSB) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

SRBCF:USA ZSB:Germany SBM:Canada

Address

C/o WeWork, 595 Burrard Street, Vancouver, BC, CAN, V7X 1L3

Website

https://www.sironabiochem.com

Sirona Biochem Corp is a development stage biotechnology company. The principal activities of the company are the development of cosmetic and pharmaceutical active ingredients which are licensed to partners in exchange for upfront, milestone, and royalty payments. The company acts as a cosmetic ingredient and drug discovery company with a proprietary technology platform with a specialization in the stabilization of carbohydrate molecules. It has a business presence in Canada and France.

Sirona Biochem (STU:ZSB) Headlines

No Headlines